Chronic Calcineurin Inhibitor Nephrotoxicity: Reflections on an Evolving Paradigm

被引:97
|
作者
Gaston, Robert S. [1 ]
机构
[1] Univ Alabama Birmingham, Div Nephrol, Birmingham, AL 35294 USA
关键词
RENAL-TRANSPLANT RECIPIENTS; GLOMERULAR-FILTRATION-RATE; MYCOPHENOLATE-MOFETIL; CYCLOSPORINE WITHDRAWAL; ANTILYMPHOCYTE GLOBULIN; KIDNEY-TRANSPLANTATION; ALLOGRAFT RECIPIENTS; PROTOCOL BIOPSIES; FOLLOW-UP; SURVIVAL;
D O I
10.2215/CJN.03820609
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Use of the calcineurin inhibitors (CND cyclosporine and tacrolimus has revolutionized solid organ transplantation. For more than 30 yr, the transplant community has dealt with nephrotoxicity attributed to these agents. Acute renal vasoconstriction (as described by many investigators, including John Curtis and colleagues) is the unequivocal consequence of their use; chronic CNI nephropathy, although indistinct in terms of histology and pathophysiology, has become accepted as a major cause of late kidney allograft failure. This article examines clinical, laboratory, and histologic findings that evolved into a paradigm that was never fully consistent with observed outcomes and new evidence that may offer an alternative interpretation for adverse events that are attributed to CNI nephrotoxicity in kidney transplant recipients. Clin I Am Soc Nephrol 4: 2029-2034, 2009 doi 10 2215/CJN 03820609
引用
收藏
页码:2029 / 2034
页数:6
相关论文
共 50 条
  • [1] Calcineurin Inhibitor Nephrotoxicity
    Naesens, Maarten
    Kuypers, Dirk R. J.
    Sarwal, Minnie
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (02): : 481 - 508
  • [2] Chronic Calcineurin Inhibitor Nephrotoxicity-Lest We Forget
    Chapman, J. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (04) : 693 - 697
  • [3] Biomarkers of calcineurin inhibitor nephrotoxicity in transplantation
    Fernando, Mangalee
    Peake, Philip W.
    Endre, Zoltan H.
    BIOMARKERS IN MEDICINE, 2014, 8 (10) : 1247 - 1262
  • [4] Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation
    Jacquet, A.
    Francois, H.
    Frangie, C.
    Ahmad, L.
    Charpentier, B.
    Durrbach, A.
    TRANSPLANT IMMUNOLOGY, 2008, 20 (1-2) : 29 - 31
  • [5] Calcineurin Inhibitor Nephrotoxicity: A Review and Perspective of the Evidence
    Issa, Naim
    Kukla, Aleksandra
    Ibrahim, Hassan N.
    AMERICAN JOURNAL OF NEPHROLOGY, 2013, 37 (06) : 602 - 612
  • [6] Is arteriolar vacuolization a predictor of calcineurin inhibitor nephrotoxicity?
    Horike, Keiji
    Takeda, Asami
    Yamaguchi, Yutaka
    Ogiyama, Yoshiaki
    Yamauchi, Yukako
    Murata, Minako
    Kawaguchi, Takehiko
    Suzuki, Taisei
    Otsuka, Yasuhiro
    Inaguma, Daijyo
    Goto, Norihiko
    Watarai, Yoshihiko
    Uchida, Kazuharu
    Morozumi, Kunio
    CLINICAL TRANSPLANTATION, 2011, 25 : 23 - 27
  • [7] Deciphering calcineurin inhibitor nephrotoxicity: a pharmacological approach
    Pallet, Nicolas
    Legendre, Christophe
    PHARMACOGENOMICS, 2010, 11 (10) : 1491 - 1501
  • [8] Histopathology of calcineurin inhibitor-induced nephrotoxicity
    Davies, DR
    Bittmann, I
    Pardo, J
    TRANSPLANTATION, 2000, 69 (12) : SS11 - SS13
  • [10] The Pharmacogenetics of Calcineurin Inhibitor-Related Nephrotoxicity
    Hesselink, Dennis A.
    Bouamar, Rachida
    van Gelder, Teun
    THERAPEUTIC DRUG MONITORING, 2010, 32 (04) : 387 - 393